Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV001225256 | SCV001397517 | pathogenic | Glanzmann thrombasthenia | 2020-09-04 | reviewed by expert panel | curation | The c.2153dup (p.Cys718Trpfs) frameshift variant has been reported in at least one compound heterozygous proband (PMID: 11798398) with a phenotype highly specific to GT. It is predicted to undergo NMD due to creation of a premature stop codon in exon 21. This variant is absent from controls in gnomAD, ExAC, and 1000 genomes. In summary, this variant meets criteria to be classified as Pathogenic for GT. GT-specific criteria applied: PVS1, PM2_supporting, and PP4_moderate. |